Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.935
-0.045 (-2.27%)
Apr 1, 2026, 2:03 PM EDT - Market open
Cibus Revenue
In the year 2025, Cibus had annual revenue of $3.64M, down -14.62%. Cibus had revenue of $1.06M in the quarter ending December 31, 2025, a decrease of -12.79%.
Revenue (ttm)
$3.64M
Revenue Growth
-14.62%
P/S Ratio
40.19
Revenue / Employee
$30,839
Employees
118
Market Cap
147.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.64M | -623.00K | -14.62% |
| Dec 31, 2024 | 4.26M | 2.45M | 134.56% |
| Dec 31, 2023 | 1.82M | 1.66M | 1,057.32% |
| Dec 31, 2022 | 157.00K | -25.83M | -99.40% |
| Dec 31, 2021 | 25.99M | 2.14M | 8.96% |
| Dec 31, 2020 | 23.85M | 16.56M | 226.91% |
| Dec 31, 2019 | 7.30M | 7.06M | 2,991.53% |
| Dec 31, 2018 | 236.00K | -272.00K | -53.54% |
| Dec 31, 2017 | 508.00K | 109.00K | 27.32% |
| Dec 31, 2016 | 399.00K | -873.00K | -68.63% |
| Dec 31, 2015 | 1.27M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 154.90M |
| Codexis | 70.39M |
| Zentalis Pharmaceuticals | 26.87M |
| Milestone Pharmaceuticals | 1.55M |
| Molecular Partners AG | 856.30K |
| Connect Biopharma Holdings | 762.00K |
CBUS News
- 6 days ago - Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock - GlobeNewsWire
- 6 days ago - Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 14 days ago - Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Cibus Reports Fourth Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call - GlobeNewsWire
- 7 weeks ago - Cibus Partnering with The John Innes Centre for UK Government's Farming Innovation Programme Precision Breeding Initiative - GlobeNewsWire
- 2 months ago - Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common Stock - GlobeNewsWire
- 2 months ago - Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock - GlobeNewsWire